Webinar: "Tools for Diagnosing and Visualizing Parkinson’s Disease" December 2023

DaTscan™ (Ioflupane I-123), which has been FDA-approved since 2011, has been a critical tool for doctors and researchers to help diagnose Parkinson’s. This year we have entered a new biological era with the discovery of a biomarker, a test that uses spinal fluid, that can detect Parkinson’s at the cellular level. And researchers are also working on a tool to visualize clumps of alpha-synuclein protein in the living brain. You might be asking yourself how these tools work together, and how are they different? How do clinicians and researchers apply them in the field? In this webinar, experts discuss how these tools are pushing science forward.
Learn more about our webinar series at www.michaeljfo....
And join our landmark study that’s changing everything about how Parkinson’s is diagnosed, treated and potentially prevented. Get started today. www.michaeljfo...

[@ulrichhr]

Ich schaue jetzt zurück in die Zukunft. Gefühlt schon das hundertsten 100 mal.

[@vijithkalladath]

I have seen so many patients with MRI show normal study of MRI Brain and the patients have typical Parkinson's disease

[@steveaird9347]

It bothers me that 90000 Americans are diagnosed every year now with Parkinson's Why I don't believe it has anything to do with pesticides I believe it has to do with medications and certain vaccines that people don't need Pharmaceutical companies are not telling doctors about All the side effects of certain vaccines and medications